SESEN BIO Forum: Community User: fb19077

Das Risiko von Penny's.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 29, 2019-- Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported modifications to its 2017 and 2018 common stock warrants, which enhance the Company’s capital raising optionality by allowing for future at-the-market (ATM) programs. “Today we took an important step to enhance our capital structure, giving us the tools to potentially build upon our financial position with a number of upcoming value-inflection points over the next year,” said Dr. Thomas Cannell, president and chief executive officer of Sesen Bio. “This was an important strategic decision to position the Company with the greatest optionality as we prepare for upcoming FDA engagements, our planned BLA submission and a potential future approval of Vicinium for patients with non-muscle invasive bladder cancer. The remainder of 2019 will be a critical period for Sesen Bio, and we look forward to continued progress across the organization.” Key Fourth Quarter 2019 Events FDA meeting on November 4, 2019 to discuss the post-marketing confirmatory trial for Vicinium FDA meeting on December 4, 2019 to discuss the submission strategy for CMC Module 3 Anticipated initiation of BLA submission under a Rolling Review in December 2019 The Company will provide more information at a Business Update on November 12, 2019 at 8:00 a.m. EST. To participate in the conference call, please dial (844) 831-3025 (domestic) or (315) 625-6887 (international) and refer to conference ID 1377227. The webcast can be accessed in the Investor Relations section of the Company’s website at www.sesenbio.com. The replay of the webcast will be available in the Investor Relations section of the Company’s website at www.sesenbio.com for 60 days following the call.

Aufgestockt

Vllt doch nicht

Du kannst bald einsteigen

Denke das kommt. Noch

War klar

Ich habe nicht aufgestockt

Krass und ich bin nicht dabei ...

Frägt

Und trägt keiner lol,würde auch zeit

Na wenn du mich fragst darf es auch weiter steigen 😜

Wenn's so bleiben würde

Einer steigt hier kräftig ein.

Hoffen wir Chart sollte über 1,25 geehn

Jetzt schon über 1,6mio Volumen, sieht nicht schlecht aus,mal sehen ob es hält.